Osel and Lactin-V Fertility Study Featured in GEN Magazine

by Osel | Feb 16, 2018 | Featured, LACTIN-V, LACTIN-V CLINICAL

A new article in Genetic Engineering and Biotechnology News (GEN) explores the role of a woman’s vaginal microbiome in infertility. The story features our collaborators in Denmark who have launched a study to determine if Lactin-V could be used to restore a more...

Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05

by Osel | Nov 1, 2011 | LACTIN-V CLINICAL

Ngugi, BM, Hemmerling, A, Bukusi, EA, Kikuvi, G, Gikunju, JShiboski, S, Frederick, DN, and Cohen, CR. Sex Transm Dis. 2011 Nov;38(11):1020-7. doi: 10.1097/OLQ.0b013e3182267ac4.     Synopsis: In the LACTIN-V Phase 2a BV study, colonization with L. crispatus...

Randomized placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection.

by Osel | Apr 14, 2011 | LACTIN-V CLINICAL

Stapelton, AE, Au-Yeung, M, Hooton, TM, Frederick, DN, Roberts, PL, Czaja, CA, Yarova-Yarovaya, Y, Fiedler, T, Cox, M and Stamm, WE. Clin Infect Dis. 2011 May;52(10):1212-7. doi: 10.1093/cid/cir183. Epub 2011 Apr 14.     Synopsis: LACTIN-V was tested in a...

Phase 2a study assessing colonization efficiency, safety and acceptability of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis.

by Osel | Dec 1, 2010 | LACTIN-V CLINICAL

Hemmerling, A, Harrison, W, Schroeder, A, Park, J, Korn, A, Shiboski, S, Foster-Rosales, A., and Cohen, CR. Sex Transm Dis. 2010 Dec;37(12):745-50. doi: 10.1097/OLQ.0b013e3181e50026.     Synopsis: LACTIN-V was tested in a randomized, blinded,...

Phase 1 dose-ranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis.

by Osel | Sep 1, 2009 | LACTIN-V CLINICAL

Hemmerling, A, Harrison, W, Schroeder, A, Park, J, Korn, A, Shiboski, S and Cohen, CR. Sex Transm Dis. 2009 Sep;36(9):564-9. doi: 10.1097/OLQ.0b013e3181a74924.     Synopsis: LACTIN-V at three dose levels was tested using a proprietary vaginal applicator in a...

Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli.

by Osel | May 15, 2009 | LACTIN-V CLINICAL

Antonio MA1, Meyn LA, Murray PJ, Busse B, Hillier SL. J Infect Dis. 2009 May 15;199(10):1506-13. doi: 10.1086/598686.     Synopsis: Sexually active females aged 14-21 years were randomized to receive either 106 or 108 colony forming units (CFU) CTV-05...